Novavax Inc (NVAX)

3.970 +0.080 (+2.06%)
Close USD Disclaimer
3.860 -0.110 (-2.771%)

Novavax Inc Company Profile

Equity Type
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Contact Information
Gaithersburg,20878 United States
240 268 2000
Top Executives
Gregg Huber Alton 58 2020 Independent Director
Richard Huntington Douglas 71 2010 Independent Director
Rachel K. King 65 2018 Independent Director
John Charles Jacobs 57 2023 CEO & Director
David M. Mott 59 2020 Independent Director
Margaret G. McGlynn 65 2020 Independent Director
James F. Young 71 2010 Independent Chairman of the Board
Richard J. Rodgers 57 2022 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles